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ABSTRACT
Sex Differences in Collateral Remodeling Following Hindlimb Arterial Occlusion
Laura Lenae Burckhardt

Clinical evidence indicates a higher incidence of peripheral arterial occlusive disease and
associated likelihood of critical limb ischemia in women, as well as worse prognosis and
decreased survival post myocardial infarction. Therefore, understanding the possible
differences in underlying vascular compensation mechanisms is crucial. With arterial
occlusions, necrosis and tissue injury can be naturally mitigated by the collateral
circulation, improving patient prognosis. Previous sex-comparison studies describing
differences in vascular remodeling are inconsistent. Therefore, the aim of this study was
to describe the effect of arterial occlusion on collateral remodeling in healthy male and
healthy reproductive-stage female mice. At 7 days following femoral artery ligation in
C57Bl/6 and BALB/c mice, there were no sex-related differences in functional
ambulatory recovery. There were no sex-related differences in mechanoadaptation
indicators in the collateral stem- vascular smooth muscle cell (VSMC) length and
overlap, with the exception of longer smooth muscle cells in male C57Bl/6 mice, VSMC
lengths 329 ± 19 verses 288 ± 13 µm, male and female. Collateral midzone luminal and
abluminal diameters, as well as wall thicknesses were not different between sexes. As
comprehensive sex-specific differences were not captured in our specific investigation of
arteriogenesis, an evaluation of microvascular remodeling in the ischemic zone and
collateral vasodilation would be of interest, as would evaluating arteriogenesis following
oophorectomy with estrogen depletion. The determination of any underlying mechanistic
sex-specific differences could be the foundation for which targeted therapeutics are
developed, which will be crucial for closing the prognosis gap between men and women
in the global treatment of peripheral arterial occlusive disease.
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INTRODUCTION
Peripheral arterial occlusive disease (PAOD), an atherosclerotic narrowing of the arteries
distal to the aortic bifurcation, affects an estimated 10 percent of the global population,
including 27 million patients in the United States and Europe [4-7]. Critical limb
ischemia (CLI), the most severe manifestation of PAOD, has 500 to 1000 new cases
diagnosed yearly per million of the population, with an estimated annual cost of 40-66
billion dollars [8]. CLI can lead to amputation or death without proper treatment, with
four-year survival rates as low as 40 percent [9]. Recent clinical evidence suggests a
higher incidence of PAOD in females, and an associated higher likelihood of critical limb
ischemia [10-15]. Women are also less likely to survive, and exhibit worse prognosis
following a myocardial infarction (MI) [16, 17]. Within women, ovariectomy before age
35 increases the risk of a nonfatal MI by 7.2 times that of premenopausal women [18]. In
patients with severe coronary artery lesions, the male sex was associated with increased
collateralization [19], therefore, these differences in outcomes could be due to underlying
molecular and cellular sex-related differences in vascular compensation methods [20, 21].

With arterial occlusions, necrosis and tissue injury can be naturally mitigated by the
collateral circulation, improving patient prognosis [22-24]. When a hemodynamicallyrelevant stenosis occurs in a main feeding artery, blood is redirected to downstream
tissues through the collateral vessel(s), which connects the high-pressure region upstream
of the stenosis to the low-pressure region downstream. The increased blood velocity and
shear stress through the collaterals initiates outward remodeling through arteriogenesis,
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allowing the collateral to improve patient prognosis by maintaining tissue perfusion [3,
25].
During this outward remodeling, vessel caliber increases in a process involving monocyte
extravasation and transformation into cytokine-, growth factor-, and enzyme-secreting
macrophages. Specific secreted agents, such as vascular endothelial growth factor A
(VEGF-A) and fibroblast growth factor 2 (FGF-2), promote proliferation of endothelial
and vascular smooth muscle
cells (VSMCs) in classical

A

arteriogenesis, Figure 1 [2632]. Although outward
remodeling usually involves
VSMC proliferation, inward
remodeling can involve both
VSMC apoptosis [33-37]
and changes in VSMC
length, increasing cellular
overlap through a process

B

described as
mechanoadaptation [38]. As
inward remodeling involves
FIGURE 1 | Arteriogenesis. (A) Classical mechanism of
arteriogenesis [1]. (B) Outward collateral remodeling, from
normal blood flow (left) to altered flow due to arterial
occlusion (right) [3].
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a continuum from changes in
apoptosis to VSMC

morphology, outward remodeling may also involve a continuum from proliferation to
changes in VSMC morphology.

In addition to VSMC proliferation,
outward remodeling also requires a
transient inflammatory response,
moderate oxidative stress, and
activation of the nitric oxide (NO)
pathway, Figure 2, with all three
processes partially modulated by
estrogens [39-42]. Estradiol levels
in men and postmenopausal women
FIGURE 2 | Nitric oxide vasodilation mechanism [1, 2].

are lower than levels in nonpregnant women, possibly explaining the differences in outward remodeling [43-45]. 17β-estradiol increases the endothelial production of nitric oxide and flow-mediated
outward remodeling following oophorectomy is rescued by 17-β-estradiol [42, 46].
Oophorectomy also increases blood pressure and decreases vessel densities in rabbits,
indicators of angiogenesis and arteriogenesis [47].

However, sex comparison of arteriogenesis without female estrogen depletion is of value
due to female hormonal cycle variation in the general population, as well as the presence
of PAOD in females prior to the average age of natural menopause [11, 43, 48, 49].
Following femoral excision, similar blood pressure and vessel densities were observed in

3

male and non-oophorectomized female rabbits, although collateral number was not
examined [47]. Furthermore, female mice without oophorectomy exhibit higher hindlimb
vascular resistance, less responsiveness to vasodilators, and more sensitivity to
vasoconstrictors following arterial occlusion [50].

The inconsistency in female flow-recovery impairment following femoral artery
occlusion or excision within a small body of literature necessitates further study [21, 47,
50]. Increased vascular resistance in female mice is suggestive of impaired collateral
enlargement, therefore we evaluated the extent and mechanisms of collateral enlargement
throughout the gracilis collateral circuit in male and female mice. The aim of this study
was test the hypothesis that healthy male mice exhibit superior collateral remodeling to
healthy reproductive-stage female mice following femoral artery ligation. This was
performed by evaluating daily hindlimb use, mechanoadaptation in the gracilis collateral
stem, and collateral enlargement in the gracilis collateral midzone.
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MATERIALS AND METHODS
Animals
All experimental procedures were performed according to the protocols approved by the
Institutional Animal Care and Use Committee (IACUC) of California Polytechnic State
University. Female and male eight-week old C57Bl/6 and BALB/c mice were obtained
from Taconic Farms, Jackson Laboratories, or Charles River Laboratories. Eight female
and eight male C57Bl/6, and six female and six male BALB/c mice were used for the
mechanoadaptation and collateral remodeling studies. All mice were maintained on a
12:12 hour light:dark cycle in a temperature controlled room in the University Vivarium.
Mice were housed by sex with littermates in micro-isolator cages, supplied with feed,
water, and enrichment (‘houses’, nesting material, and tubes), and inspected daily.

Collateral Enlargement Model
Collateral enlargement was induced in the superficial gracilis collaterals by ligating the
femoral artery between the profunda femoris and popliteal branches of the left hindlimb,
as described previously [51]. Briefly, mice were anesthetized using 1-3% isoflourane gas
at an oxygen flow rate of 0.8-1.2 l⋅min-1, administered through a ‘nose-cone’, and given
pre-operative analgesic (buprenorphine, 0.075 mg·kg-1 subcutaneous). Hair on the medial
hindlimb was depilated and the surgical area was disinfected with chlorohexidine
diacetate. Mice were placed supine on a heated surgical stage, adjusted to maintain a core
body temperature of 35°C. Ophthalmic ointment was applied to the eyes to avoid corneal
desiccation.
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A small skin incision (1-2 cm) was made on the middle, medial aspect of the left thigh,
with subcutaneous connective tissue blunt dissected to maximize surgical exposure.
Throughout the procedure, the incision site was irrigated with sterile phosphate buffered
saline (PBS) to prevent tissue desiccation. To expose the ligation site, the epigastric fat
pad was reflected medially, and the femoral artery was blunt dissected from the
neurovascular bundle before ligation with 6.0 silk suture distal to the epigastric branch
and proximal to the popliteal branch [51]. The skin was closed using 7.0 polypropylene
suture. For control, the surgical procedure outlined above was performed on the
contralateral hindlimb, with the exception of ligating the femoral artery. Animals were
given post-operative buprenorphine (0.075 mg·kg-1), and supplied with buprenorphine
water (0.01 mg·ml-1) for approximately 2-3 days.

Clinical Ambulation Scoring
Following surgery, animals were observed daily for ambulation, and scored from 0-3
based on hindpaw range of motion, as described previously [52]. A dragging hindpaw
was scored as a 3, no plantar flexion and constant dorsiflexion a 2, some plantar flexion a
1, and normal use a 0. Animals were monitored until normal ambulation was observed on
two consecutive days, or until day-7 post ligation.

Perfusion Fixation and Microfil Infusion
In preparation for vascular casting and immunofluorescence, mice were perfusion fixed
with paraformaldehyde. Through a thoracotomy, an incision was made in the apex of the
heart into the left ventricle, and a catheter was inserted and secured with a vascular
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clamp, Figure 3A. A cycle of 40 ml vasodilator cocktail heated to 37 °C (5 U·µL-1
heparin, 10-3 M sodium nitroprusside, 10-4 M adenosine, in PBS), followed by 5 ml 4%
paraformaldehyde (PFA), was injected through the catheter with a syringe pump (5
ml·min-1), Figure 3B. Following fixation, microfil agents were combined, and 1 ml was
injected (0.5 ml·min-1). Once the Microfil perfused distal to the knee, both ankles were
ligated with silk suture to prevent entry into venous circulation through ankle A-V shunts,
Figure 3C. Microfil infusion continued until the casting agent reached the anterior
gracilis collateral (approximately 3 ml of additional solution). Post infusion, the exposed
tissue was covered with plastic wrap and Microfil polymer cured overnight at room
temperature. The anterior gracilis muscle and profunda femoris artery were resected and
post fixed in 4% PFA for approximately 24 hours before rinsing and storing in PBS at 4
°C.

A

B

C

FIGURE 3 | Perfusion fixation and Microfil injection methods. (A) Thoracotomy with
catheter insertion. (B) Setup with syringe pump. (C) Murine ankles ligated during Microfil
injection.
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Immunofluorescence
Immunofluorescence was used to determine collateral vessel diameters and smooth
muscle cell mechanoadaptation. Whole gracilis anterior muscles were stained with αsmooth muscle actin (Sigma Aldrich Anti-Actin α-Smooth Muscle Cy3™ Antibody,
C6198) in a solution with 0.1% saponin and 2% BSA in PBS for 3 days at 4°C. After
staining, muscles were washed in 0.1% saponin in PBS 3x for 20 minutes at room
temperature, and PBS for 30 minutes. The samples were mounted onto depression slides
with 50:50 PBS:glycerol to clear.

The midzone of the anterior gracilis collateral was captured with widefield fluorescence
microscopy (α-smooth muscle actin) and widefield microscopy (Microfil cast). All
anterior gracilis collateral inner and outer diameters were measured at the collateral
midzone in three locations using ImageJ.

Confocal microscopy was used to visualize smooth muscle cells around each artery to
assess smooth muscle cell overlap and length (mechanoadaptation indicators). Utilizing a
40x oil immersion objective, images of the collateral stem region of the profunda femoris
artery were captured with Fluoview Viewer software (Olympus, FV10-ASW 4.1). Image
stacks in the z-direction were captured with 1-micron slices for approximately half the
diameter for each artery. To assess mechanoadaptation in the collateral stem, the z-stacks
of the profunda femoris were merged into single, 3-D reconstructions, and smooth muscle
cell overlap between the individual cells and smooth muscle cell length were measured
using ImageJ software, as described previously [38, 53]. Briefly, a 100µm length of
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artery was delineated from each 3D reconstruction, and average VSMC length for each
vessel, Lv, was determined using Equation 1 below [38, 53]:’
𝐿# = 4𝜋𝑅# 𝐹(𝑆+ + 𝑆- )/𝑇#

(Eq. 1)

In equation 1, Lv is the average VSMC length, Rv the radius of the artery, F the fraction
of vessel circumference in which measurements were made, Sw the number of wrap cells,
St the length of all tapered cells divided by the length of one wrap cell, and Tv the number
of taper cells.

Statistical Analysis
Differences in daily ambulation scores were determined using a repeated measures
analysis of variance (ANOVA). Differences in intersex or interstrain ambulation scores,
collateral stem VSMC lengths and overlaps, collateral midzone inner and outer
diameters, and collateral midzone wall thicknesses were determined using independent ttests. All values are expressed as mean ± standard error of the mean.
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RESULTS
Functional Impairment Following Femoral Artery Ligation
Previous investigations of male-female differences in response to arterial occlusion
suggested that deficits observed in female mice were likely attributable to reduced
collateral remodeling or fewer collateral number [50]. However, because recovery from
femoral artery resection involves both collateral enlargement in the thigh along with
angiogenesis and capillary arterialization in the leg [54, 55], we sought to evaluate the
impact of female sex in an arterial occlusion model that involves primarily collateral
enlargement [56]. Surprisingly, there was no difference in hindlimb use between male
and female C57Bl/6, which was normalized by 3.9 ± 0.4 days for both, Figure 4. If
anything, C57Bl/6 female mice may have recovered normal hindlimb use before the
males, but this was only statistically different at the day-5 time point. Female C57Bl/6
mice were statistically different at days 1, 2, and 5 from the rest of the days scored for
that group, and male C57Bl/6 were different at days 1 and 6. Female BALB/c mice were
different at days 4 and 6 from the rest of the days scored for that group, and male
BALB/c mice were different at days 4, 5, and 6. As expected, BALB/c mice regained
normal hindlimb function more slowly, but there was no difference between males and
females, 5.8 ± 0.2 and 6.0 ± 0 days, respectively. As ambulation was only scored up to 6
days, these data suggest that BALB/c mice hindlimb function did not return to normal use
during the experiment.

Although no difference in hindlimb use suggests a similar degree of collateral
enlargement between male and female mice, hindlimb use is a sufficiently coarse
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assessment that depends upon more than collateral flow. Therefore, we specifically
evaluated collateral remodeling between male and female mice following femoral artery
ligation.

A
∞

B

4

BALB/c Female
BALB/c Male

Ambulation Score

C57Bl/6 Female
C57Bl/6 Male

3
2
1
0

*

0

1

2

3

4

5

6

Days Post-Ligation
FIGURE 4 | Hindlimb ambulation scoring following femoral artery ligation in BALB/c
and C57Bl/6 mice. (A) Days to normal ambulation in BALB/c female (n=6) and male mice
(n=6), and C57Bl/6 male (n=13) and female (n=13) mice. The infinity sign (∞) indicates mice
did not return to normal hindlimb function during experiment. (B) Daily ambulation scores for
BALB/c female (n=6) and male (n=6) mice, and C57Bl/6 female (n=13) and male (n=13)
mice. *P<0.05 male verses female intrastrain.
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Mechanoadaptation in the Collateral Stem
Although the collateral stem enlarges following femoral artery ligation, the absence of
smooth muscle cell proliferation suggests the enlargement is not due to typical
arteriogenesis [57, 58]. To test the hypothesis that enlargement in the collateral stem
occurs via mechanoadaptation, change in vascular diameter by the modification of
VSMC length and overlap, and to determine if female mice are deficient in this process,
we assessed smooth muscle cell length and overlap utilizing confocal microscopy at day
7 in both sham-operated and ligated profunda femoris arteries in male and female
C57Bl/6 mice. Although the native anatomy of smooth muscle cells in the collateral stem
of C57Bl/6 male and female mice was not different, VSMCs were longer in males
following remodeling, and VSMC lengths in both sexes were greater than the
contralateral controls, Figure 5C. Consistent with mechanoadaptation, smooth muscle
cell overlap decreased at day-7 post ligation in both sexes, but there was no difference
between male and female mice Figure 5D.
As BALB/c mice have lower collateral density and decreased collateral remodeling when
compared to C57Bl/6 mice at day-21 following ligation, we examined enlargement in this
model [52, 56]. There was no difference in VSMC lengths of male and female collateral
stems in BALB/c mice, and remodeling was consistent, with all VSMC lengths greater in
both male and female mice following ligation than the contralateral controls.
Smooth muscle cell overlap decreased at day-7 post ligation in both male and female
BALB/c mice, consistent with mechanoadaptation, Figure 5D. Despite the native
anatomy of the BALB/c mice differing with VSMC overlap shorter in male than female
mice in the non-ligated group, there was no difference in remodeled collateral stem
12

VSMC overlaps between male and female BALB/c mice.

A

B

C
B

D

FIGURE 5 | Indicators of mechanoadaptation in BALB/c and C57Bl/6 Mice. (A)
Representative image of profunda femoris artery under confocal microscopy (40x). (B)
Representative image of smooth muscle cell overlap (yellow) and length (green). (C)
Smooth muscle cell lengths in the profunda femoris artery of day-7 post-ligation and
control hindlimbs in BALB/c female (n=4,5) and male (n=4,5) mice, and C57Bl/6
female (n=8,7) and male mice (n=6,7). (D) Smooth muscle cell overlap in the
profunda femoris artery of day-7 post-ligation and control hindlimbs in BALB/c
female (n=4,5) and male (n=4,5) mice, and C57Bl/6 female (n=8,7) and male (n=6,7)
mice. *P<0.05 verses control conditions. **P<0.05 for male versus female C57.
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Anterior Gracilis Collateral Remodeling Post-Femoral Artery Ligation
Having compared the mechanoadaptation events between males and females, we next
evaluated the arteriogenesis response in the collateral midzone within the anterior gracilis
muscle [56]. To determine if female mice exhibit impaired arteriogenesis, we measured
outward remodeling (based on luminal diameter) and measured abluminal diameter so
that we could calculate wall thicknesses and identify any differences in the type of
remodeling that occurred (i.e. hypertrophic, eutrophic, or hypotrophic), Figure 6, in male
and female C57Bl/6 and BALB/c mice. As expected, robust outward remodeling
occurred, as the luminal diameter was larger for all ligated gracilis collaterals compared
to the respective contralateral control, for both male and female C57Bl/6 mice, Figure
6E. The abluminal diameter was also larger for both male and female C57Bl/6 mice, and
even larger than expected based on the increase in luminal diameter, suggesting a
hypertrophic outward remodeling. Figure 6F. Indeed, measurements of wall thickness
confirmed a hypertrophic outward remodeling, which was not different between male and
female C57Bl/6 mice. Figure 6G. There was no difference between male and female
C57Bl/6 mice for luminal diameter, abluminal diameter, or wall thickness in the
remodeled collateral.

With no evidence of intersex differences in collateral midzone outward remodeling in
C57Bl/6 mice, we examined if there was an impairment in collateral remodeling for
BALB/c female mice. Like the C57Bl/6 mice, the lumen was larger for all ligated gracilis
collaterals compared to the respective contralateral control, within both males and
females, Figure 6E. The abluminal diameter was also greater for both male and female
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mice, comparing the ligated gracilis collaterals to the contralateral control, Figure 6F.
Both males and females exhibited larger wall thicknesses for the day-7 remodeled
collaterals compared to the contralateral control, Figure 6G. There was no difference
between male and female BALB/c mice for luminal diameter, abluminal diameter, or
wall thickness in the remodeled or control collaterals.
A

B

C

D

E

F

G

FIGURE 6 | Anterior gracilis collateral remodeling in C57Bl/6 and BALB/c mice following
femoral artery ligation. (A) Representative day-7 post ligation collateral abluminal diameter
alpha-VSMC stained (10x). (B) Representative day-7 post ligation collateral luminal-diameter
polymer perfused (10x). (C) Representative alpha-SMA control anterior gracilis collateral (10x).
(D) Representative control collateral luminal-diameter polymer perfused (10x). (E) Luminal
diameter of the anterior gracilis collateral of day-7 post-ligation and control hindlimbs in BALB/c
female (n=6,5) and male (n=6,6) mice, and C57Bl/6 female (n=4,5) and male (n=4,5) mice. (F)
Abluminal diameter of the anterior gracilis collateral of day-7 post-ligation and control hindlimbs
in BALB/c female (n=6,5) and male (n=6,6) mice, and C57BL/6 female (n=4,5) and male (n=4,5)
mice. (G) Wall thickness of the anterior gracilis collateral of day-7 post-ligation and control
hindlimbs in BALB/c female (n=6,5) and male (n=6,6) mice, and C57Bl/6 female (n=4,5) and
male (n=4,5) mice. *P<0.05 male verses female control conditions.
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DISCUSSION
Contemporary clinical evidence indicates a higher incidence of PAOD and associated
likelihood of critical limb ischemia in women [10-15, 59]. Women are also less likely to
survive, and exhibit worse prognosis following myocardial infarction [16, 17]. With these
differences possibly due to discrepancies in vascular compensation, developing effective
therapeutics necessitates understanding the mechanisms underlying these potential
differences [20, 21]. Previous work is inconsistent on the impact of female sex on flow
recovery following arterial occlusion, but suggested an impairment in collateral growth
[21, 47, 50]. Therefore, we described the effect of arterial occlusion on collateral
remodeling in healthy male and healthy reproductive-stage female mice.

In functional ambulatory recovery evaluation, both male and female C57Bl/6 mice
regained normal hindlimb function more quickly than BALB/c mice post-ligation, Figure
4. The inter-strain findings are consistent with previous observations that BALB/c mice
have greater hindlimb use impairment at days 3 and 7 when compared to C57Bl/6 models
[52]. Furthermore, BALB/c mice had greater myofiber atrophy, greater myocyte
apoptosis, and attenuated myogenic regulatory gene expression and stress-response
signaling following hindlimb ischemia, with evidence in functional impairment [60]. No
difference existed in days to normal ambulation between male and female mice with
normal estrous cycles in either strain.

In exploring the outward vascular remodeling mechanisms underlying the ambulatory
recovery, it is known that the collateral stem outwardly remodels following an upstream
16

occlusion in male mice [57]. Although the collateral stem enlarges, the lack of VSMC
proliferation in this area suggests the enlargement was due to other processes [58, 61-63].
Repositioning of VSMCs due to an altered mechanical environment is established, as
physical alignment and reorientation of isolated cultured VSMCs in a position
perpendicular to the stretch vector occurs due to cyclic stretch, and arteriolar inward
remodeling in response to norepinephrine and angiotensin [64-66]. As such, we tested the
hypothesis that enlargement in the collateral stem occurs via VSMC mechanoadaptation,
and that female mice are deficient in this process. Although all smooth muscle cell
lengths increased relative to their contralateral control, surprisingly, the only sex
difference in remodeling was longer VSMCs in C57Bl/6 males compared to females. As
the native VSMC lengths between C57Bl/6 mice were not different, these males may
exhibit the ability to elongate VSMCs greater than females of the same strain, although
this did not affect the diameter of the vessel in a measurable way. VSMC shape and
migration are altered by many different stimuli, including humoral factors (ANGII,
TGFb1, ET-1, etc.), neuronal contributors, intercellular VSMC paracrine factors,
endothelial cell influences (NO, etc.), and mechanical forces such as active stress and
strain [67]. Estrogen levels in men and postmenopausal women are lower than levels in
non-pregnant women [41-43], and estrogen has been shown to cause an increase in
norepinephrine levels [68]. Norepinephrine exposure has resulted in shortening of
VSMCs [38]. Therefore, it is possible that if the females had higher baseline levels of
norepinephrine, their VSMCs lengths may not lengthen as robustly, resulting in the
sexual dimorphism seen. In examining an additional aspect of mechanoadaptation, all
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VSMC overlaps decreased relative to their contralateral control, but there were no sexrelated remodeling differences among BALB/c or C57Bl/6 strains, Figure 5.

As the anterior gracilis collateral exhibits smooth muscle cell proliferation, evidence of
typical arteriogenesis [56, 58], we tested the hypothesis that female mice exhibit impaired
arteriogenesis in this vessel. No differences were found between C57Bl/6 and BALB/c
mice, consistent with prior day-7 collateral arteriole remodeling results, in which male
BALB/c collateral outward remodeling was impaired at day-3 post arterial occlusion, but
showed no difference at day-7 [56]. Vessel diameters and wall thickness were larger in
the remodeled vessel than the control vessel in all sexes and strains. The only exception
was the wall thickness of C57Bl/6 female mice. This measurement had a large amount of
variability, which may be due to variations in the mice estrous cycles. 17-β-estradiol
levels are variable during the cycle [69], and 17-β-estradiol increases the endothelial
production of nitric oxide [46], which is an endothelial-derived vasodilator [70]. Nitric
oxide diffuses into VSMCs, initiating a cascade that activates protein kinase G. This then
regulates calcium concentrations and sensitization, and causes actin and myosin dynamic
alterations that result in cellular relaxation, possibly altering wall thickness [71].
However, no difference existed between male and female C57Bl/6 mice for inner
diameter, outer diameter, or wall thickness in the remodeled or control collaterals, Figure
6. Therefore, this lack of difference in diameters may suggest the lack of increase in wall
thickness to be artifact. As this finding suggests no obvious anatomical remodeling
differences in the anterior gracilis collateral midzone of male and female mice, there may
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be other factors accounting for any flow recovery differences previously observed, such
as increased vascular resistance in the ischemic zone in females [50].

Fewer preexisting collaterals in females with unimpaired remodeling, or dysregulated
capillary arterialization and angiogenesis may explain increased vascular resistance in
females, with collaterals remodeling to the same extent. However, no difference between
male and female C57Bl/6 mice in number of α-smooth muscle actin-positive vessels was
found at baseline in the midpoint of the semimembranosus muscle [50]. Despite this lack
of difference, the small sample size of no more than 5 mice in each group leaves this
possibility to be considered [50]. Furthermore, the collateral distribution between male
and females may be different, so although there was no difference at the midpoint of the
semimembranosus muscle, there may be fewer preexisting collaterals in other areas of the
hindlimb. Despite no difference at day-7 post ligation in α-smooth muscle actin-positive
vessels compared to baseline for females, there was an increase in males. This increase is
suggestive of preexisting capillaries being transformed into collaterals, possibly due to
pericyte recruitment, known as capillary arterialization [72, 73]. In a basic examination of
angiogenesis, female C57Bl/6 mice had less fewer red blood cell-containing vessels in a
Matrigel Plug Assay compared to males after 5 days, indicating dysregulation [50]. An
increased ability in either of these mechanisms would explain lower vascular resistance in
males.

Alternatively, higher vascular resistance in female mice [46] may be due to impaired
vasodilation in the ischemic zone, even without vessel growth impairment or difference
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in baseline collateral density [50, 74]. Because reports concerning the impact of arterial
occlusion on smooth muscle-dependent and endothelium-dependent vasodilation are
inconsistent, it is unclear what component of the remodeling process may be affected.
Vasodilation is impaired in response to endothelium-dependent agents in immature
collaterals in animal models [75-79], but upon maturation is either restored [78] or
continually impaired [79]. This may be explained by endothelial dysfunction induced by
inflammatory conditions during remodeling [80], or an increase in collateral flow [81].
Hypercholesterolemia and ovariectomy in female mice each lead to impaired endothelialdependent vasodilation in resistance vessels [102], so it is possible that additional comorbidities or estrogen deficiency may precipitate sex-dependent causal effects on
vasodilation impairment, possibly leading to higher female vascular resistance depending
on female mice position in the estrous cycle [82].

Impaired vasodilation may be partially contributed to smooth muscle cell dysfunction
[83]. This dysfunction is suggested by diminished endothelium-dependent and
independent dilation responses in immature feed arteries that are restored after maturation
[83]. Although feed arteries and collaterals remodel differently, endothelium-independent
vasodilation is also impaired in collateral vessels [79, 84, 85]. This impairment could be
due to smooth muscle dysfunction caused by the smooth muscle cell phenotype change
during proliferation in immature collaterals [86, 87]. Although there is conflicting
evidence that vasodilation responses to sodium nitroprusside are intact at day-14
following the induction of chronic ischemia [79], nitric oxide-induced, smooth muscledependent dilation is impaired in intramuscular arterioles at 5-weeks post chronic
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ischemia induction [79, 85]. Although the mechanism of the impairment is unknown in
these reports, there is a possible relation to oxidative stress. This stress increases with
chronic ischemia [88], impairing dilation response in the obese Zucker rat to sodium
nitroprusside [89]. Impaired dilation may have increased vascular resistance in female
C57Bl/6 mice, as they were less responsive to vasodilators at day-7 following femoral
artery excision [50].

This research had several limitations regarding its interpretation. One of the potential
limitations of this study is the non-standardization of the estrus cycle. This cycle in mice
is approximately 4-5 days in length, consisting of the four phases: proestrus, estrus,
metestrus and diestrus [90]. Through the duration of the study, the female mice were
randomly cycling through these phases, undergoing several cycles. Although this nonstandardization is not optimal in determining correlative mechanisms, it more accurately
reflects the healthy female general population hormonal cycle variation. Another
limitation is the variation in ambulation scorers throughout the week. A different lab
member is in charge of determining an ambulation score for the mice every day, which
may have led to variation in the data due to the subjective nature of the measure. To
mitigate this potential variation, it may be best to have one individual assign scores
throughout the duration of the experiment, possibly limiting the data collection to days 1,
3, and 6 post ligation to ease workload and still capture a comprehensive view of
recovery. In addition, training videos or sessions could be created to minimize variation
between scorers within the lab. Another possible limitation is the variation in time of day

21

in which the ambulation data was collected, so moving forward it would be
recommended to score the mice at a similar time each day for consistency.

In summary, the aim of these studies was to describe the effect of arterial occlusion on
collateral remodeling in male and healthy reproductive stage female mice. The collateral
stem enlarged seemingly due to mechanoadaptation in both BALB/c and C57Bl/6 mice.
There were no major sex-related differences in the gracilis collateral stem or midzone
remodeling or resultant functional ambulation, with the exception of longer VSMCs in
male C57Bl/6 mice, at day-7 post femoral artery ligation in the collateral stem. As
clinical evidence indicates a higher incidence of PAOD and associated likelihood of
critical limb ischemia in women, as well as worse prognosis and decreased survival post
myocardial infarction, understanding the possible differences in underlying vascular
compensation mechanisms is crucial [10-17, 59]. As these differences were not captured
in our specific investigation of arteriogenesis, an evaluation of microvascular remodeling
in the ischemic zone and collateral vasodilation would be of interest. Furthermore, as
oophorectomy reduces flow-mediated outward remodeling and decreased vessel densities
in mice [46], arteriogenesis should be evaluated in the hindlimb following oophorectomy
with estrogen depletion. 17-β-estradiol increases the endothelial production of nitric
oxide, and flow-mediated outward remodeling following oophorectomy is rescued by 17β-estradiol, with increased age a risk factor for PAOD development [11, 42, 46]. The
determination of any underlying mechanistic sex-specific differences could be the
foundation in which targeted therapeutics are developed, crucial for closing the prognosis
gap between men and women in the global treatment of PAOD.
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APPENDICES
Appendix A: Raw Images
Wideview Microscopy (10x)
C57Bl/6 Females:
A

B

N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A

B

N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil (Did not use)
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A

B

N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=3 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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A

B

N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
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A

B

N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
C57Bl/6 Males:
A
B

N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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A

B

N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
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A

B

N=3 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A

B

N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil (Did not use)
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A

B

N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=6 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=6 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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BALB/C Females:
A

B

N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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A

B

N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
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A

B

N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=6 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=6 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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BALB/C Males:
A

B

N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
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A

B

N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

A

B
N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=3 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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A

B

N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A
B

N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
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A

B

N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
A

B

N=6 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth
Muscle Actin B) Microfil
A
B

N=6 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil
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Confocal Images (40x)
C57Bl/6 Females:
A

B

N=1 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A
B

N=3 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=5 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A

B

N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
49

A

B

N=7 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control

N=8 Profunda Femoris Artery Day-7 Post-Ligation
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C57Bl/6 Males:
A

B

N=1 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A

B

N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=3 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A

B

N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control

52

A

B

N=5 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A

B

N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=7 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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BALB/C Females:
A

B

N=1 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A
B

N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=3 A) Profunda Femoris Artery Day-7 Post-Ligation (Did not use) B) Profunda
Femoris Artery Control
A
B

N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

B

N=5 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
A
B

N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control (Did not use)
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BALB/C Males:

N=1Profunda Femoris Artery Day-7 Post-Ligation
A

B

N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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A

N=3 Profunda Femoris Artery Control
B

N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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N=5 Profunda Femoris Artery Control
A

B

N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery
Control
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Appendix B: Tables
Table I. Days to Normal Ambulation Post-Femoral Artery Ligation in C57Bl/6 and BALB/c
Mice

C57Bl/6
BALB/c

Sex
Males

n
13

Days to Normal Ambulation ± SE
3.9 ± 0.4

Females
Males

13
6

3.9 ± 0.4
5.8 ± 0.2

Females

6

6.0 ± 0.0

Table II. Daily Ambulation Scoring in C57Bl/6 and BALB/c Mice

Sex

n

Day 1 PostLigation ±
SE

Day 2 PostLigation
± SE

Day 3 PostLigation
± SE

Day 4 PostLigation
± SE

Day 5 PostLigation
± SE

Day 6 PostLigation
± SE

Males

13

1.6 ± 0.2

0.8 ± 0.1

0.5 ± 0.2

0.4 ± 0.2

0.3 ± 0.1

0.0 ± 0.0

Females

13

1.4 ±0.2

1.0 ± 0

0.1 ± 0.1

0.1 ± 0.1

0.0 ± 0.0

0.3 ± 0.2

Males

6

3.0 ± 0

2.0 ± 0.0

2.4 ± 0.2

1.8 ± 0.3

1.7 ± 0.3

1.0 ± 0.3

Females

6

2.8 ± 0.2

1.8 ± 0.4

2.3 ± 0.2

1.7 ± 0.2

1.3 ± 0.2

1.7 ± 0.2

C57Bl/6

BALB/c

Table III. Indicators of Mechanoadaptation in C57Bl/6 and BALB/c Mice
Sex
Males
C57Bl/6
Females

Males
BALB/c
Females

Limb
Day-7
Post-Ligation

n

VSMC Length (µm)
± SE

Overlap (µm)
± SE

6

329 ± 19

19 ± 2

Control

7

273 ± 15

27 ± 2

Day-7
Post-Ligation

8

288 ± 13

16 ± 1

Control

7

235 ± 19

26 ± 2

Day-7
Post-Ligation

4

325 ± 9

24 ± 2

Control

5

280 ± 10

29 ± 1

4

327 ± 10

22 ± 2

5

297 ± 11

35 ± 2

Day-7
Post-Ligation
Control
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Table IV. Anterior Gracilis Collateral Remodeling in C57Bl/6 and BALB/c Mice.

Sex
Males
C57Bl/6
Females

Males
BALB/c
Females

Limb
Day-7
Post-Ligation

n

Outer Diameter
(µm)
± SE

4

93 ± 9

70 ± 7

12 ± 1

Control

5

50 ± 5

38 ± 4

6±1

Day-7
Post-Ligation

4

95 ± 12

62 ± 7

17 ± 6

Control

5

46 ± 5

29 ± 3

8±1

Day-7
Post-Ligation

6

103 ± 9

67 ± 7

18 ± 2

Control

6

50 ± 7

37 ± 4

7±3

6

100 ± 7

70 ± 6

17 ± 1

5

46 ± 3

35 ± 3

6±1

Day-7
Post-Ligation
Control
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Inner Diameter
(µm)
± SE

Wall Thickness
(µm)
± SE

Appendix C: Femoral Artery Ligation Protocol
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Appendix D: Perfusion Fixation Protocol
Date ______________

Perfusion Fixation

Mouse Information
DOB: ___________________
Sex: ____________________
Tag: ____________________
Genotype/strain: __________
Cage: ___________________
Weight(g): _________________

Initials____________

Fixation
____33. Remove hair on both legs by shaving &
depilation
____34. Tape animal in supine position to 4X4
gauze sponge over heating pad
____35. Expose muscles of interest and blunt
dissect to aid in removal post-fixation,
then cover with saran wrap
____36. Fill 20mL syringe with 20 mL warm
Vaso D, load into syringe pump and
attach catheter
____37. Flow liquid through the catheter to the
tip to prevent air from being injected
into circulatory system
____38. Lift skin from muscle in abdominal
region and cut a window over the
sternum
____39. Lift sternum and cut connective tissue
under
____40. Use bone scissors in hole to quickly cut
through the ribs to the armpit on both
sides
____41. Clamp sternum with castroviejos and
reflect towards mouse’s head
____42. Cut diaphragm with curved iris scissors
to open chest cavity
____43. Cut away excess tissue around the heart
____44. Make a small incision in the apex of the
heart
____45. Insert catheter and clamp with vascular
clamp and cut right atrium
____46. Inject Vaso D solution into animal
approximately 20mL X 2 (5mL/min),
soaking up excess blood and fluids with
gauze sponges
____47. Inject 5 mL PFA (4 mL/min)
____48. Dissect out muscles of interest using fine
forceps and microdissection scissors
____49. Turn off water bath, cover scope, turn
off oxygen, turn off isofluorane, and
clean instruments

Materials
Non-Sterilize Dissection Instruments
____1.
Forceps (1)
____2.
Fine forceps (2)
____3.
Bone scissors (1)
____4.
Curved Iris scissors (1)
____5.
Microdissection scissors (1)
____6.
Vascular clamp (1)
____7.
Castroviejos
Obtained in surgery suite
____8.
Tape
____9.
20 mL syringes (2)
____10. 5 mL syringe (1)
____11. Syringe pump
____12. Petri-dish
____13. Bench cover
____14. Depilatory cream
____15. Clippers
____16. Veterinary ointment
____17. Heating pad
____18. Catheter
____19. Non-sterile saline
____20. Cotton swabs
____21. Gauze sponges
____22. Saran wrap
Vasodilator Cocktail Preparation
____23. Turn on water bath to 37ºC
____24. 400 µL heparin
____25. 1mL SNP(orange)
____26. 600µL Adenosine(clear)
____27. 38mL PBS solution
____28. 5 mL 4% Paraformaldehyde (PFA)
____29. Thaw SNP, Adenosine and PFA
____30. Add heparin, SNP, Adenosine, and PBS
solution together in a 50mL conical
____31. Place vasodilator cocktail in water bath

Notes
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________

Procedure Preparation
____32. Obtain saline filled petri-dish, cotton
swab, and instruments
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Appendix E: Microfil Protocol
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Appendix F: ASMA Staining Protocol
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Appendix G: Confocal Protocol
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Appendix H: Inadequate Methods
There were several methods that did provide an adequate assessment of the data. These
methods are outlined below, along with suggestions for possible mitigation of challenges.
Transilluminator
To attempt to visualize the red blood cell column to measure inner diameter in the
gracilis collateral midzone, a transilluminator was used. A transilluminator is a waterresistant probe with a light at the distal end designed to fit behind the dissected anterior
gracilis in vivo. The light was placed directly behind the collateral midzone, and images
were captured utilizing an Olympic BXFM intravital microscope. However, the method
did not provide images with clearly discernable red blood cell columns, so inner diameter
measurements were not successfully recorded. Possible reasons for failure are depth of
vessels resulting in challenging focusing for microscope, or incorrect microscope
settings. Suggestions for possible mitigation include adjustment of light settings or
location of probe to result in clearer images, adjustment of imaging variables to result in
clearer images, removal of tissue overlying gracilis muscle, and adjustment of postprocessing of images. A sample image is seen below.

In vivo gracilis collateral midzone visualization
utilizing transilluminator.

Endothelial Lectin Stain
To attempt to visualize endothelial cells to measure inner diameter in the gracilis
collateral midzone, a lectin stain was used. Lectin specifically binds to glycoproteins
located in the basal membrane of endothelial cells [91], and can be visualized using
widefield fluorescent microscopy. This protocol can be seen in Appendix I. In addition to
the recommended incubation time and concentration in the protocol, I also performed
1:40 4 hour, 1:20 2 hour, 1:20 4 hour, and 1:20 overnight incubation. However, upon
imaging there was only nonspecific activation of cells, not allowing clear visualization of
the endothelium. As lectin depends on diffusion through tissue, it is possible that the
gracilis collateral is too deep in the anterior gracilis muscle for the molecule to bind to the
endothelium. Suggestions for possible mitigation include adjustment of antibody
68

concentrations, incubation times, and permeabilizing agents to allow for binding to the
collateral endothelium, adjustment of widefield fluorescent filters, and adjustment of
post-processing of images. A sample image of a lectin stained image overlaid to an alphasmooth muscle actin image is seen below, with no clear visualization of the endothelium.
A

B

Lectin stain. (A) Lectin positive image of 1:20 dilution incubated for 4 hours. (B) Lectin
positive image (green) overlaid with alpha-smooth muscle actin positive (red).

Evans Blue Dye
To visualize inner diameter of the gracilis collateral midzone, Evans Blue Dye was
utilized. Evan’s blue dye binds to serum albumin, resulting in luminal staining of vessels,
allowing visualization upon microscopy [92]. It is injected into the ventral artery in the
tail. However, upon intravital microscopy using a transilluminator, clear visualization of
the inner diameter was not obtained. This may be due to diffusion of the dye to other
tissues, as the myofibers also turned blue, as well as challenges previously discussed with
transillumination. Potential mitigation includes adjustment of transillumination
technique, concentration of dye or volume injected, a different method of injection such
as intracardiac following perfusion fixation, adjustment of widefield microscopy brightlight settings, or adjustment of post-processing of images.
Estrous Cycle Determination
To assign where a female mouse was in the murine estrous
cycle on day-7 post ligation, vaginal visualization was
utilized, as outlined in a prior study [93]. Images were
captured using a hand-held digital camera of the vaginal
area, and then compared to the reference images in the
publication. However, as there were no personnel in the lab
trained in this subjective method, there was no way to
confirm the correct assignment of the estrous cycle. To
mitigate this moving forward, collaboration with the group
who created this method would be ideal to ensure proper
training and success in assignment.
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Example image for vaginal
visualization.

Length Density and Volume Fraction
To determine vessel density in the anterior gracilis muscle along the stem, midzone and
reentry portions, length density and volume fraction calculations were utilized following
alpha-smooth muscle actin staining as described in Appendix I, and imaged using
widefield microscopy. Images were taken at the stem, midzone, and reentry regions of the
vessel and imported into Rapid Analysis of Vessel Elements (RAVE) software. Length
density is a measure of total arteriole length per unit area of tissue, and volume fraction
represents the total length of all vessels divided by total pixel area, with the method
outlined in a prior publication [94]. However, because images were not in focus all the
way through the depth of collateral location in the muscle, it was difficult to use the
software to assign a correct binary to distinguish between vascular and muscular tissue.
As the images were taken on the widefield microscope, utilization of the confocal
microscope and creation of a z-stack would be ideal for the uniform focus of the vessels
necessary for RAVE software utilization.
A

B

C

Vessel Density Measurement. (A) Rapid Analysis of Vessel Elements (RAVE)
Software GUI. (B,C) Representative alpha-smooth muscle actin positive images
that were uploaded for assessment.
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Appendix I: Lectin Stain Protocol
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